Senior Specialist, Quantitative Pharmacology and Pharmacometrics – Immuno-Oncology; QP‑IO

Senior Scientist Quantitative Pharmacology and Pharmacometrics – Immune/Oncology

Our company is a global healthcare leader with a diversified portfolio of prescription medicines, vaccines, and animal health products. We are recognized as an industry leader in immuno-oncology (IO) and vaccines discovery and development. For more than a century, our company has translated scientific innovation into medicines and vaccines that improve and save lives worldwide—anchored in ethical integrity, scientific excellence, and a clear mission to transform global health.

Our company is on a quest for cures and is committed to being the world's premier, most research-intensive biopharmaceutical company. Our Research & Development division is a world-class scientific organization that brings together leading discovery capabilities and small molecule/biologics R&D expertise to create breakthrough science and redefine how we treat serious diseases.

The Quantitative Pharmacology and Pharmacometrics – Immune/Oncology (QP2-IO) Department of our Company's Research Laboratories is seeking a curious and collaborative Senior Scientist to support our rapidly expanding oncology pipelines.

As a senior specialist you will be part of a cross-functional teams of experienced scientists to discover and develop novel therapeutic agents in oncology. The senior specialist is a skilled quantitative scientist, with a good understanding of the strategic elements of drug discovery and development. The senior specialist should demonstrate collaborative work spirit and excellent communication skills.

Within QP2-IO, you have a unique opportunity to accelerate your professional career as a quantitative drug developer taking advantage of our end-to-end pipeline support in one of the world's most research-intensive biopharmaceutical companies.

Primary Responsibilities:

• Contribute to the development of model-based strategies (translational PK/PD strategies, mechanistic model, POPPK/PD, clinical trial simulations, etc) for quantitative analyses, within and across development programs and/or departments, to inform and optimize drug discovery and all phases of drug development including, but not limited to dose selection, clinical trial design, and go/no-go decisions.
• Represent QP2-IO on oncology discovery, early clinical development and late clinical development teams, leveraging quantitative approaches to drive streamlined development of programs within our growing portfolio.
• Collaborate with other functional areas, as well as with external vendors and partners, on activities related to study design, protocol development, study execution, reporting and interpretation of data.

• A Ph.D. with 0-2 years experience
OR
• PharmD or MS or equivalent degree with preferably 2-4 years of relevant experience, where "experience" means having a record of increasing responsibility and independence in a similar role in pharmaceutical drug development, regulatory agency, or academia.

• Educational background in biopharmaceutics, pharmaceutical sciences, pharmacometrics, chemical/biomedical engineering, or a related field.
• Experience in performing population PK, PK/PD analyses using standard pharmacometrics software (e.g. NONMEM, Monolix, Phoenix, etc.).
• Good written and verbal communication, interdisciplinary collaboration, and problem scoping and planning.

• Knowledge in oncology clinical drug development programs.
• Skills in experimental design, mathematical problem solving, critical data analysis/interpretation, and statistics.
• Scientific understanding of biopharmaceutical and ADME properties of small molecules and/or biologics.